Provenge (Sipuleucel-T) Suspension, 250ML


Indications and Reactions:

Role Indications Reactions
Primary
Prostate Cancer Metastatic 98.1%
Prostate Cancer 1.0%
Chills 0.3%
Nausea 0.3%
Neoplasm Malignant 0.3%
Disease Progression 15.7%
Culture Positive 10.7%
Pyrexia 8.2%
Vomiting 6.9%
Chills 6.3%
Thrombosis In Device 6.3%
Device Related Infection 4.4%
Tachycardia 4.4%
Nausea 3.8%
Poor Venous Access 3.8%
Prostatic Specific Antigen Increased 3.8%
Thrombosis 3.8%
Hospitalisation 3.1%
Pneumonia 3.1%
Weight Decreased 3.1%
Anaemia 2.5%
Dehydration 2.5%
Haemoglobin Decreased 2.5%
Myocardial Infarction 2.5%
Nasopharyngitis 2.5%

Drug Data